Northern Trust
THRD

Northern Trust’s Third Harmonic Bio THRD Stock Holding History

Northern Trust’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-197,549
Closed -$1.07M – 4535
2025
Q2 		$1.07M Sell
197,549
-3,904
-2% -$19.5K ﹤0.01% 3347
2025
Q1 		$699K Buy
201,453
+9,113
+5% +$44.2K ﹤0.01% 3429
2024
Q4 		$1.98M Buy
192,340
+903
+0.5% +$11.3K ﹤0.01% 3031
2024
Q3 		$2.59M Buy
191,437
+39,471
+26% +$489K ﹤0.01% 2838
2024
Q2 		$1.98M Sell
151,966
-3,612
-2% -$44.7K ﹤0.01% 2903
2024
Q1 		$1.47M Sell
155,578
-4,026
-3% -$39.1K ﹤0.01% 3127
2023
Q4 		$1.75M Buy
159,604
+5,494
+4% +$43.5K ﹤0.01% 3067
2023
Q3 		$985K Buy
154,110
+9,238
+6% +$56.5K ﹤0.01% 3304
2023
Q2 		$697K Buy
144,872
+42,724
+42% +$203K ﹤0.01% 3455
2023
Q1 		$421K Sell
102,148
-785
-0.8% -$3.33K ﹤0.01% 3536
2022
Q4 		$443K Buy
+102,933
New +$1.72M ﹤0.01% 3550

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AB
Amalgamated Bank New York $13.1B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northern Trust's THRD Position: Q3 2025 in Review

Northern Trust sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 197,549 shares — an estimated $1.07M sold.

Northern Trust first reported a position in THRD in Q4 2022 and held it in 11 quarters. The position peaked at $2.59M in Q3 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Northern Trust reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Northern Trust sold 197,549 Third Harmonic Bio shares in Q3 2025, an estimated $1.07M.
  • Northern Trust first reported a position in Third Harmonic Bio in Q4 2022 and held it in 11 quarters.
  • Northern Trust's Third Harmonic Bio position peaked at $2.59M in Q3 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Northern Trust's 13F filing for Q3 2025, filed 14 Nov 2025.